EUVIMEDEUVIMED entdecken
Crossref

N-(Pyridin-2-yl)ureas incorporating an arylsulfonamide pharmacophore as potential adjuvants in lung cancer therapy

Svetlana O Baykova, Olga V Solodyankina, Pavel K Kozhukhov, Ilya Tatarinov, Konstantin N Semenov, Vladimir V Sharoyko, Sergey V Baykov, Vadim P Boyarskiy

Bioorganic & Medicinal Chemistry Letters · 2026-11 · 130820

DOI: 10.1016/j.bmcl.2026.130820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2026-11. Verfasst von Svetlana O Baykova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Saint Petersburg State University, 7/9 Universitetskaya Nab., Saint Petersburg 199034, Russian Federation. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Sankt-Peterburgskij gosudarstvennyj universitet aèrokosmičeskogo priborostroeniâ, Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Carbonic anhydrase IXCombination therapyHypoxiaIsosteric replacementLung cancerMolecular modelingN-pyridylureasPrimary sulfonamides

Autor:innen und Institutionen

  • Institute of Chemistry, Saint Petersburg State University, 7/9 Universitetskaya Nab., Saint Petersburg 199034, Russian Federation.
  • Pavlov First Saint Petersburg State Medical University, 6-8 L'va Tolstogo Str., Saint Petersburg 197022, Russian Federation.
  • National Research University Higher School of Economics, 7 Vavilova Str., Moscow 117312, Russian Federation; N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, 47 Leninsky Prospekt, Moscow 119991…
  • Pavlov First Saint Petersburg State Medical University, 6-8 L'va Tolstogo Str., Saint Petersburg 197022, Russian Federation; Institute of Experimental Medicine, 12 Academician Pavlov Str., Saint Petersburg 197022, Russi…
  • Institute of Chemistry, Saint Petersburg State University, 7/9 Universitetskaya Nab., Saint Petersburg 199034, Russian Federation; Institute of Experimental Medicine, 12 Academician Pavlov Str., Saint Petersburg 197022,…

Förderung

  • Sankt-Peterburgskij gosudarstvennyj universitet aèrokosmičeskogo priborostroeniâ
  • Russian Science Foundation

Zitieren

APA

Baykova, S. O., Solodyankina, O. V., Kozhukhov, P. K., Tatarinov, I., Semenov, K. N., Sharoyko, V. V., Baykov, S. V., & Boyarskiy, V. P. (2026). N-(Pyridin-2-yl)ureas incorporating an arylsulfonamide pharmacophore as potential adjuvants in lung cancer therapy. Bioorganic & Medicinal Chemistry Letters, 130820. https://doi.org/10.1016/j.bmcl.2026.130820

Vancouver

Baykova SO, Solodyankina OV, Kozhukhov PK, Tatarinov I, Semenov KN, Sharoyko VV, et al. N-(Pyridin-2-yl)ureas incorporating an arylsulfonamide pharmacophore as potential adjuvants in lung cancer therapy. Bioorganic & Medicinal Chemistry Letters. 2026:130820. doi:10.1016/j.bmcl.2026.130820

BibTeX
@article{Baykova2026,
  author = {Baykova, Svetlana O and Solodyankina, Olga V and Kozhukhov, Pavel K and Tatarinov, Ilya and Semenov, Konstantin N and Sharoyko, Vladimir V and Baykov, Sergey V and Boyarskiy, Vadim P},
  title = {N-(Pyridin-2-yl)ureas incorporating an arylsulfonamide pharmacophore as potential adjuvants in lung cancer therapy},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2026},
  pages = {130820},
  doi = {10.1016/j.bmcl.2026.130820}
}
Kostenlos starten →